Denis Larsimont Selected Research

Denis Larsimont Research Topics

Disease

72	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2002
64	Neoplasms (Cancer) 01/2024 - 05/2002
9	Neoplasm Metastasis (Metastasis) 06/2020 - 10/2008
5	Triple Negative Breast Neoplasms 12/2023 - 01/2016
5	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 12/2005
4	Carcinoma (Carcinomatosis) 02/2023 - 10/2016
3	Pathologic Complete Response 01/2018 - 10/2013
3	Tertiary Lymphoid Structures 01/2018 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2016
2	Papillary Thyroid Cancer 01/2019 - 04/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 08/2010
2	Disease Progression 01/2016 - 07/2015
1	Inflammatory Breast Neoplasms 12/2023
1	Pericarditis 12/2023
1	Carcinosarcoma 02/2023
1	Solitary Fibrous Tumors 10/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Ductal Carcinoma 01/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Margins of Excision 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Cicatrix (Scar) 02/2018

Drug/Important Bio-Agent (IBA)

16	Estrogen ReceptorsIBA 01/2023 - 03/2003
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2008
10	Phenobarbital (Luminal)FDA Link 12/2023 - 07/2005
9	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2024 - 01/2016
9	ParaffinIBA 08/2017 - 07/2002
8	AnthracyclinesIBA 08/2017 - 05/2002
7	Hormones (Hormone)IBA 09/2022 - 10/2005
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2002
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 12/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2005
5	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2013
5	Trastuzumab (Herceptin)FDA Link 01/2018 - 10/2006
5	Tamoxifen FDA LinkGeneric 02/2016 - 12/2004
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2013 - 10/2004
4	durvalumabIBA 12/2023 - 08/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 01/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 10/2004
4	ErbB Receptors (EGF Receptor)IBA 09/2022 - 12/2005
4	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2017
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2017
4	Formaldehyde (Formol)FDA Link 08/2017 - 03/2008
4	Messenger RNA (mRNA)IBA 10/2013 - 12/2006
4	Docetaxel (Taxotere)FDA Link 05/2012 - 12/2002
3	Letrozole (Femara)FDA LinkGeneric 08/2022 - 02/2016
3	human ERBB2 proteinIBA 01/2018 - 12/2009
3	Epirubicin (Ellence)FDA LinkGeneric 10/2013 - 05/2002
3	trioctyl phosphine oxide (TOPO)IBA 12/2008 - 05/2002
2	taxaneIBA 12/2023 - 05/2012
2	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 11/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 05/2002
2	Adenosine (Adenocard)FDA LinkGeneric 12/2023 - 08/2021
2	Circulating Tumor DNAIBA 09/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 08/2017
2	MucinsIBA 01/2021 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 06/2009
2	Aromatase InhibitorsIBA 01/2021 - 06/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2019
2	ChemokinesIBA 01/2019 - 07/2013
2	CytokinesIBA 01/2019 - 07/2013
2	AntigensIBA 01/2018 - 07/2002
2	Estrogens (Estrogen)FDA Link 01/2018 - 06/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2016 - 08/2009
2	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 12/2006
2	tau Proteins (tau Protein)IBA 07/2008 - 12/2002
2	TubulinIBA 07/2008 - 12/2002
1	LigandsIBA 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	CarbonIBA 01/2023
1	CollagenIBA 10/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	Denosumab FDA Link 12/2020
1	Indicators and Reagents (Reagents)IBA 06/2020
1	SirtuinsIBA 02/2020
1	atezolizumabIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Progesterone FDA LinkGeneric 01/2019
1	Pyruvate CarboxylaseIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	AntibodiesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Cyclin D1IBA 01/2018
1	Differentiation AntigensIBA 01/2018

Therapy/Procedure

19	Therapeutics 01/2024 - 05/2002
10	Drug Therapy (Chemotherapy) 12/2023 - 07/2008
6	Neoadjuvant Therapy 12/2023 - 01/2013
5	Immunotherapy 11/2023 - 11/2017
4	Adjuvant Chemotherapy 08/2021 - 08/2014
3	Radiotherapy 12/2023 - 02/2020
3	Segmental Mastectomy (Lumpectomy) 10/2023 - 01/2021
2	Cytoreduction Surgical Procedures 02/2018 - 12/2016
1	Intravenous Injections 08/2020